So, the mutations in PALB2 normally not only resulted in typical FA phenotypes, but also increased the occurrence of pediatric malignancies, Wilm’s tumors, and medulloblastomas (Reid et al., 2007). The gene discussed is PALB2; the disease is Nephroblastoma.